“…The next important case was Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc [2014] RPC 21. With the agreement of Lewison and Kitchin LJJ, I summarised the effect of that decision in Sandoz Limited and another v G.D. Searle LLC and another [2018] EWC…”
“…In Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc [2014] RPC 21, Human Genome Sciences (“HGS”) was the proprietor of a patent which disclosed the existence of a novel member of the TNF ligand superfamily of cytokines called…”